Study of Giant Axonal Neuropathy in German Patients
Author Information
Author(s): Andrea Gangfuß, Gido Goj, Silke Polz, Adela Della Marina, Andreas Hentschel, Katja Ahlbory, Timo Deba, Urania Kotzaeridou, Elisabeth Schuler, Astrid Pechmann, Uta Diebold, Gerhard Kurlemann, Lucas Heinzkyll, Dirk Schmitt, Kevin Rostasy, Tobias Ruck, Johann Böhm, Andreas Roos, Ulrike Schara-Schmidt
Primary Institution: University Duisburg-Essen, Essen, Germany
Hypothesis
What are the clinical, genetic, and proteomic characteristics of patients with Giant Axonal Neuropathy (GAN) in a German cohort?
Conclusion
The study identified diverse genetic variants and clinical features in a cohort of 15 GAN patients, revealing significant insights into the disease's progression and potential biomarkers.
Supporting Evidence
- 14 out of 15 patients had a confirmed diagnosis through genetic testing.
- Eight different GAN variants were identified, with four classified as pathogenic.
- Proteomic analysis revealed dysregulation of 111 proteins related to various biological processes.
Takeaway
This study looked at 15 kids with a rare disease called Giant Axonal Neuropathy to understand how it affects them and what causes it.
Methodology
A cross-sectional study collecting clinical, genetic, and epidemiological data from GAN patients treated by pediatric neurologists in German-speaking countries.
Potential Biases
Potential bias due to the retrospective nature of data collection and reliance on clinician reports.
Limitations
The study was limited to data from German-speaking countries and did not include feedback from clinicians in Austria and Switzerland.
Participant Demographics
The cohort included 15 patients, with a median age of 11.7 years, predominantly male (53.3%) and with diverse origins including Syria and Turkey.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website